2 results
Approved WMOCompleted
To assess accuracy and reliability of new-to-market CGM systems in patients with type 1 diabetes.
Approved WMOPending
The purpose of this study is to evaluate the safety and efficacy of ALXN1720 for the treatment of gMG in adults with autoantibodies against AChR (AChR+). The study will also evaluate the safety and performance of the administration device (the PFS-…